fda restrictions on compounding bpc-157 is reviewing seven peptides this week, BPC-157, MOTS-c, and Epitalon among them. Committee meets Thursday and Friday, and the likely outcome is tighter pharmacies. Read past the headline FDA Panel Votes to Recommend
FDA Panel Votes to Recommend BPC 157 for Pharmacy Compounding HealingMaps Industry Update: Interim 503A and 503B Bulks Lists New Revisions healthcare #medicine #peptides #longevitymedicine #compoundingpharmacy #functionalmedicine #preventivemedicine #clinicalresearch #regulatoryaffairs #integrativemedicine Vinse Seremet 10 comments FDA's own advisory committee voted 8 6 Thursday. BPC 157, on the compounding list now, for ulcerative colitis. FDA staff argued against it, laid out the data gaps, the whole case. Panel overruled them
Pay in 4 interest-free payments of $5.75 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22

